Lupin eyes deals up to $1B in growth push; NJ wins grant to retrain laid-off pharma workers;

@FiercePharma: India's Lupin joins hunt for branded products to beef up a generics portfolio. Has $1B to spend. Report | Follow @FiercePharma

@EricPFierce: Bayer & Merck have weighed in on the big pay-for-delay case that the Supreme Court takes up this month. More | Follow @EricPFierce

> Lupin is eyeing a pediatric drug brand in the U.S. and a generics company in Brazil as it shops for assets to beef up its sales. Report

> The Federal Trade Commission argues that generic drugmakers should have access to samples of the drugs they're trying to copy, even if those drugs fall under a risk-management plan. Report

> New Jersey won a federal grant to incentivize companies to hire former pharmaceutical industry workers; the money will pay for training and subsidize salaries. Report

> Florida economic development officials approved a $500,000 incentive package to help attract a Venezuelan drugmaker and 100 jobs to the state. Report

> To continue to grow in a crowded generics market, Indian drugmakers need to focus on new drug-delivery devices and technologies, as well as other types of "super-generics," experts say. Report

> A top Cipla Medpro shareholder said it would ask India's Cipla to hike its buyout offer past the current $500 million. Report

Medical Device News

 @FierceMedDev: For GenMark, more flu was good news in 2012. More | Follow @FierceMedDev

 @MarkHFierce: France's EyeTechCare, with $13M in new funding, will pursue U.S. approval of its glaucoma ultrasound medical device. More | Follow @MarkHFierce

 @DamianFierce: Luminex is on board to handle companion diagnostics for Merck's blockbuster hopeful Alzheimer's drug. More | Follow @DamianFierce

> Analysts: Life Tech's suitors may balk at $15B price tag. More

> Zoll wins German patent battle over intravascular temperature management tech. More

Biotech News

 @FierceBiotech: Editor's corner: Will biotech grow in China and India without much VC help? More | Follow @FierceBiotech

@JohnCFierce: Weird deal. Receptos gets a PhII-ready AbbVie antibody. AbbVie has option to co-dev, co-promote. If it's worth anything, why farm it out? | Follow @JohnCFierce

@RyanMFierce: Takeda expanded a discovery alliance with Sripps Florida (pharma outsourcing more discovery work to academics.) Release | Follow @RyanMFierce

> J&J opens new innovation center in quest for more early-stage deals. Story

> Domain opens shop in China with plans to seed biotech startups, do deals. News

Drug Delivery News

@MichaelGFierce: Vaginal nanogel with bee venom could prevent HIV infection. Story | Follow @MichaelGFierce

> Terumo evens with Abbott's Xience in drug-eluting stent study. News

> Study: Artificial pancreas improves overnight care in diabetic children. Article

> Shape-shifting proteins could aid drug delivery for cancer, infections. More

> Celgene drops $13M on Presage's 3-D drug delivery platform. Report

And Finally... Heart patients may be prescribed too many drugs, and eliminating some may improve care, cardiologists say. Report